| ARDS | Control | ||
---|---|---|---|---|
 | T0 (<24 h) | T1 (3–5 d) | T2 (7–9 d) |  |
Total Phospholipids [μg/ml] | 31.9 ± 5.0 | 24.3 ± 4.2 | 27.9 ± 5.1 | 35.9 ± 4.8 |
Phospholipid-to-protein ratio | 0.043 ± 0.010 *** | 0.052 ± 0.021 | 0.109 ± 0.024 §§ | 0.461 ± 0.030 |
PC [%] | 73.3 ± 2.0 ** | 72.4 ± 3.6 | 74.7 ± 2.2 | 81.3 ± 1.6 |
PG [%] | 3.6 ± 0.9 *** | 2.8 ± 0.8 | 5.3 ± 0.7 § | 11.6 ± 1.1 |
PS [%] | 6.5 ± 1.1 *** | 5.4 ± 0.9 | 6.1 ± 1.2 | 1.8 ± 0.7 |
PI [%] | 5.3 ± 0.9 * | 5.3 ± 1.2 | 5.9 ± 1.3 | 2.5 ± 0.3 |
PE [%] | 4.8 ± 1.0 * | 6.9 ± 1.6 | 3.3 ± 0.8 | 1.4 ± 0.4 |
SPH [%] | 5.0 ± 0.7 *** | 5.6 ± 0.9 | 2.9 ± 0.7 § | 0.6 ± 0.3 |
PC 16:0/16:0 | 26.81 ± 1.61 *** | 32.98 ± 2.36 § | 40.16 ± 1.89 §§§ | 60.65 ± 1.27 |
PC 16:0/18:1 | 20.43 ± 1.71 *** | 15.37 ± 2.06 § | 12.57 ± 0.79 §§ | 9.68 ± 0.49 |
PC 16:0/18:2 | 10.33 ± 0.80 *** | 10.00 ± 1.49 | 8.53 ± 0.55 § | 5.43 ± 0.31 |
PC 16:0/16:1 | 7.76 ± 0.53 * | 6.46 ± 0.40 § | 9.79 ± 0.80 § | 4.84 ± 0.55 |
PC 16:0/14:0 | 6.76 ± 1.50 | 6.39 ± 0.51 | 7.67 ± 1.44 | 7.18 ± 0.64 |
PC 16:0/20:4 | 4.36 ± 0.46 ** | 2.63 ± 0.32 § | 2.30 ± 0.55 § | 1.95 ± 0.19 |
PC 18:0/18:2 | 4.52 ± 0.47 * | 3.99 ± 0.39 | 2.98 ± 0.45 § | 1.54 ± 0.45 |
PC 18:1/18/1 | 4.00 ± 0.23 | 3.70 ± 0.61 | 2.52 ± 0.22 § | 3.22 ± 0.39 |
PC 18:0/18:1 | 2.67 ± 0.37 | 3.66 ± 0.52 § | 2.02 ± 0.18 | 2.14 ± 0.29 |
SP-A [% PL] | 2.61 ± 0.32 ** | 3.07 ± 0.57 | 3.61 ± 0.27 § | 4.12 ± 0.09 |
SP-B [% PL] | 2.29 ± 0.32 ** | 2.93 ± 0.43 | 2.94 ± 0.41 | 3.71 ± 0.32 |
SP-C [% PL] | 1.19 ± 0.25 * | 1.34 ± 0.23 | 1.37 ± 0.26 | 2.28 ± 0.22 |
SP-D [ng/ml] | 14.9 ± 2.9 | 18.8 ± 7.1 | 18.4 ± 5.8 | 14.2 ± 2.2 |
γ ads [mN/m] | 39.0 ± 1.3 | 33.8 ± 4.7 | 33.2 ± 3.7 | 19.1 ± 0.9 |